Plain-English translation of NCT07374471 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Phase 1/2 — A combined trial that checks safety and dosing while also starting to look at whether the treatment works.
This study is testing a new medication called in the form of a capsule to see if it can help people with moderate to severe ulcerative colitis. Half of the participants will receive , and half will receive a placebo (a capsule with no active medication), but no one will know which they're getting. The researchers want to understand whether the medication is safe and whether it reduces inflammation and symptoms.
Many people with ulcerative colitis don't respond well enough to current treatments, or they can't tolerate them. This study aims to find out if this new treatment could be a better option for people whose disease isn't well controlled with existing medications.
You likely qualify if…
You likely don't qualify if…
You will visit the clinic multiple times for appointments during which you'll take either the experimental medication or a placebo by mouth. You'll undergo colonoscopy or flexible sigmoidoscopy examinations to assess how your colon is responding. Throughout the study, researchers will collect blood samples to monitor your safety and understand how the medication works in your body. The exact schedule and duration will be detailed when you are enrolled, but the study involves regular check-ins and imaging to track whether the treatment is helping.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
Moldova